The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for State of the Art Medical Products sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
State of the Art Medical Products is a medical equipment company that sells and distributes cardiovascular and surgical equipment. The company’s cardiovascular products are used in cardiac surgery, vascular surgery, and interventional radiology. Its surgical products are used in sterile processing, neurosurgery, thoracic surgery, ENT, laparoscopic surgery, and orthopaedic surgery. The company distributes its products in Maine, New Hampshire, Vermont, Massachusetts, Connecticut, New York, New Jersey, Delaware, Maryland, and the eastern half of Pennsylvania in the US. SOTA is headquartered in Cedar Grove, New Jersey, the US.
The key metrics of State of the Art Medical Products related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As State of the Art Medical Products is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as State of the Art Medical Products.
For a detailed understanding of the performance of State of the Art Medical Products, buy the report here.